Enliven Therapeutics, Inc.
USD36.03
+0.51 (+1.44%)
CEO
Richard A. Fair
IPO Date
2020-03-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$35.40
Prev. Close
$35.52
Day Low
$34.90
Day High
$36.23
52W Low
$14.79
52W High
$48.53
Market Cap
$2.19B
Volume
0.70M
| 3,475 |
| $39.53 |
| 20 May 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | S-Sale | Disposed | 1,302 | $40.25 |
| 20 May 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | S-Sale | Disposed | 223 | $41.21 |
| 20 May 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | M-Exempt | Disposed | 5,000 | $2.48 |
| 21 Apr 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | M-Exempt | Acquired | 5,000 | $2.48 |
| 21 Apr 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | S-Sale | Disposed | 140 | $45.81 |
| 21 Apr 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | S-Sale | Disposed | 2,419 | $47.39 |
| 21 Apr 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | S-Sale | Disposed | 2,441 | $48.06 |
| 21 Apr 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | M-Exempt | Disposed | 5,000 | $2.48 |